Effaclar Duo+M

Global action acne treatment. Proven efficacy on acne lesions for all skin phototypes.

Formulated with Phylobioma that acts efffectively on C. acnes phylotype IA1. For mono, adjunctive and maintenance therapy.

Key Ingredients

Phylobioma^TM: to decrease C. acnes phylotype IA1 quantity and act on the microbiome

Salicylic Acid + LHA: keratolytic action to exfoliate clogged pores.

Aqua Posae Filiformis: to rebalance the skin's microbiome.

Niacinamide + La Roche-Posay Thermal Water: to soothe inflammation.

Effaclar Duo+M is acne consensus compliant

International experts in acne management published a consensus on the recommendations and use of skincare in acne management in mono, adjunctive and maintenance therapy.

Proven clinical efficacy

Daily care for monotherapy, maintenance or as an adjunct to prescription treatment for moderate to severe acne. Efficacy on all phototypes.

AT DAY 28:
-57% INFLAMMATORY LESIONS (papules & pustules)¹

AT DAY 56:
-42% POST-INFLAMMATORY HYPERPIGMENTATION (red & brown marks)¹
-56% RETENTIONAL LESIONS (blackheads & microcysts)²
^{*Self-assessment, 100 women, analysis after 1 app.

1.Clinical study, 15 patients, 2/day, . Half-face DUO(+), Half-face placebo.Lesion count at D28 & D56.

2.Clinical stuady, 45 patients, 1/day effaclar duo(+) & effaclar foaming gel 2/day, 4 weeks.}